找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Atlas of Clinical PET-CT in Treatment Response Evaluation in Oncology; Stefano Fanti,Gopinath Gnanasegaran,Ignasi Carrió Book 2021 Springe

[復制鏈接]
查看: 21999|回復: 56
樓主
發(fā)表于 2025-3-21 19:47:25 | 只看該作者 |倒序瀏覽 |閱讀模式
期刊全稱Atlas of Clinical PET-CT in Treatment Response Evaluation in Oncology
影響因子2023Stefano Fanti,Gopinath Gnanasegaran,Ignasi Carrió
視頻videohttp://file.papertrans.cn/165/164131/164131.mp4
發(fā)行地址Explores the evaluation of treatment response.Presents Case-based discussions with evidence-based teaching points.Contains High-quality images and excellent authors
圖書封面Titlebook: Atlas of Clinical PET-CT in Treatment Response Evaluation in Oncology;  Stefano Fanti,Gopinath Gnanasegaran,Ignasi Carrió Book 2021 Springe
影響因子This atlas is a superb guide to the use of PET-CT for the evaluation of treatment response in oncology patients based on its ability to assess tumor metabolic status. The first part of the book explains the role of PET-CT in response evaluation in different treatment settings. For comparison, overviews of the value and limitations of CT alone, PET alone, and anatomical and functional MRI are included. Guidance is also provided on the reporting of PET-CT scans in post-therapy scenarios. The second part of the book describes and illustrates the use of PET-CT with FDG and other tracers to assess the treatment response of malignancies at different anatomic sites. Featuring a wealth of images, informative case-based discussion, and evidence-based teaching points, these disease-specific chapters clearly demonstrate the key role that PET-CT can play in distinguishing early responders from patients who are non-responders or are resistant to treatment. Prompt and accurate evaluation of treatment response is vital as we enter the era of individualized medicine, and this atlas will persuade readers of the considerable advantages of PET-CT over conventional radiological and clinical methods.
Pindex Book 2021
The information of publication is updating

書目名稱Atlas of Clinical PET-CT in Treatment Response Evaluation in Oncology影響因子(影響力)




書目名稱Atlas of Clinical PET-CT in Treatment Response Evaluation in Oncology影響因子(影響力)學科排名




書目名稱Atlas of Clinical PET-CT in Treatment Response Evaluation in Oncology網絡公開度




書目名稱Atlas of Clinical PET-CT in Treatment Response Evaluation in Oncology網絡公開度學科排名




書目名稱Atlas of Clinical PET-CT in Treatment Response Evaluation in Oncology被引頻次




書目名稱Atlas of Clinical PET-CT in Treatment Response Evaluation in Oncology被引頻次學科排名




書目名稱Atlas of Clinical PET-CT in Treatment Response Evaluation in Oncology年度引用




書目名稱Atlas of Clinical PET-CT in Treatment Response Evaluation in Oncology年度引用學科排名




書目名稱Atlas of Clinical PET-CT in Treatment Response Evaluation in Oncology讀者反饋




書目名稱Atlas of Clinical PET-CT in Treatment Response Evaluation in Oncology讀者反饋學科排名




單選投票, 共有 0 人參與投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用戶組沒有投票權限
沙發(fā)
發(fā)表于 2025-3-21 21:42:32 | 只看該作者
Jacqueline Schuldt,Helmut Niegemanns from nonresponders. FDG PET/CT can distinguish viable from the nonviable disease. Still, false positives do occur because of posttreatment inflammatory changes due to the uptake of FDG in macrophages and activated leukocytes. We present multiple case scenarios of FDG PET/CT in response assessment of esophageal and gastric malignancy.
板凳
發(fā)表于 2025-3-22 01:50:15 | 只看該作者
地板
發(fā)表于 2025-3-22 05:13:31 | 只看該作者
5#
發(fā)表于 2025-3-22 10:53:01 | 只看該作者
6#
發(fā)表于 2025-3-22 13:05:11 | 只看該作者
7#
發(fā)表于 2025-3-22 17:26:35 | 只看該作者
8#
發(fā)表于 2025-3-22 23:10:54 | 只看該作者
18F-FDG PET/CT and Non 18F-FDG-PET/CT in Treatment Response Evaluation in Neuro-Oncologyo overcome some of the limitations of CE-MRI. There has been significant development in the use of PET imaging for a number of use cases particularly in the field of neuro-oncology. In this chapter, we review examples of several PET Tracers in Treatment Response Evaluation in Neuro-oncology.
9#
發(fā)表于 2025-3-23 02:46:44 | 只看該作者
PET/CT in the Assessment of Treatment Response in Hepatobiliary, Gall Bladder and Pancreatic Malignase to neoadjuvant therapy and detecting recurrent disease. There are several advantages and limitations of using .F-FDG PET in the assessment of treatment response. This chapter illustrates clinical examples of .F-FDG PET/CT in the assessment of treatment response in hepatobiliary, gall bladder and pancreatic malignancies.
10#
發(fā)表于 2025-3-23 06:43:46 | 只看該作者
 關于派博傳思  派博傳思旗下網站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網 吾愛論文網 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經驗總結 SCIENCEGARD IMPACTFACTOR 派博系數 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網安備110108008328) GMT+8, 2025-10-13 12:32
Copyright © 2001-2015 派博傳思   京公網安備110108008328 版權所有 All rights reserved
快速回復 返回頂部 返回列表
武平县| 灯塔市| 江都市| 屏东市| 沭阳县| 穆棱市| 融水| 当雄县| 五河县| 南投市| 黔南| 宾阳县| 乌海市| 天峨县| 黎川县| 黄陵县| 新干县| 香格里拉县| 衡山县| 北川| 阿拉善右旗| 商南县| 辽源市| 兴业县| 斗六市| 桑日县| 延吉市| 鄂州市| 高州市| 延川县| 沾益县| 乌恰县| 鸡泽县| 商都县| 平潭县| 铅山县| 惠来县| 合肥市| 通榆县| 彰化市| 赤水市|